Market Research Reports

Wednesday 5 August 2020

Perfusion Market Profile, Trends and Applications By 2023

Perfusion Market Information, By Type (Cardiopulmonary Bypass, Isolated Limb Perfusion, & Others), By Application (Heart, Lung, & Others), By Device Type (Normothermic Machine Perfusion, & Others), By End User (Hospital, & Others) - Global Forecast Till 2023

The perfusion market is growing pervasively mainly attributing to the increasing prevalence of chronic diseases associated with lungs, heart, liver, and kidneys which are the result of changing lifestyle. Over the last three decades, perfusions have evolved hugely, demonstrating remarkable advances which are leading to driving the growth of the market. Simultaneously, there has been a remarkable growth in the awareness about related surgeries required to managing these diseases which, as a result, are escalating the market on the global platform.

According to an eminent research firm, Market Research Future (MRFR) the perfusion market is growing steadily, globally, and is expected to continue growing in the years to come. In its recently published study report MRFR asserts that the global perfusion market will garner a valuation of USD 1,527 MN by 2023 posting approximately 4.1% CAGR throughout the assessment period (2017-2023).

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/888

Additionally factors such as the increasing population and urbanization led by the improving economic conditions that are increasingly expanding the access to the quality healthcare expanding the market size of profusion. Moreover, rising cases of lifestyle diseases, smoking, and consumption of alcohol which eventually lead to increasing the cases of organ failure are boosting the growth of the market.

On the other hand, factors such as the lack of awareness regarding perfusion systems in developing countries are impeding market growth.

Global Perfusion Market - Segments

The MRFR analysis is segmented into five key dynamics for enhanced understanding.

By Type : Cardiopulmonary Bypass, Extracorporeal Membrane Oxygenation, and Isolated Limb Perfusion among others.

By Application : Lungs, Heart, Liver, and Kidneys among others.

By Device Type : Hypothermic Machine Perfusion and Normothermic Machine Perfusion among others.

By End User : Hospital, Specialty Clinics, Medical Research Centers, and Academic Institutes among others.

By Regions : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Perfusion Market - Regional Analysis

North American region heading with the increasing number of organ transplant surgeries dominates the global perfusion market, accounting for the largest share. Moreover, factors such as technological advancement and high per capita healthcare expenditures are expected to spur the market growth in the region.

The U.S. and Canada led by the rising number of chronic diseases associated with lungs, heart, liver, and kidneys lead the perfusion market in North America. Furthermore, the growing number of heart and kidney bypass surgeries and the growing prevalence of coronary diseases alongside the rapid uptake of advanced technologies and devices in the surgical process drive the growth in the regional market.

The perfusion market in the European region accounts for the second-largest market, globally. The region witnesses the increasing number of kidney & heart bypass procedures. Factors such as the availability of specialty care services in hospitals & tertiary care centers alongside the rising prevalence of cardiovascular diseases and the increasing demand for the treatment options of cardiovascular diseases escalate the market growth in the region.

Furthermore, the increasing healthcare expenditures led by the resurging economy in the region and spreading awareness towards bypass procedures impact the market growth in the region, positively.

The Asia Pacific perfusion market is emerging as a profitable market, worldwide. Factors such as the proliferating healthcare sector along with the flourishing medical tourism market in highly populated countries like India and China drive the regional market. Also, the rising cases of patients suffering from coronary diseases, increasing geriatric populace and spreading awareness about healthcare foster the growth of the regional market.

Global Perfusion Market - Competitive Analysis

Highly competitive, the Perfusion market appears fragmented owing to the presence of several well-established market players. These players through strategic initiatives such as acquisition, partnership, expansion, product & technology launch, and collaboration, try to gain a competitive advantage and maintain their positions in the market. Huge investments are being transpired in the R&D to bring betterments in surgical procedures and to develop devices that are on a different level entirely compared to their competition.

Major Players

Medtronic (Ireland), Getinge AB (Sweden), LivaNova PLC (U.K.), XENIOS AG (Germany), Terumo Medical Corporation (Japan), Lifeline Scientific, Inc. (U.S.), Repligen Corporation (U.S.), XVIVO Perfusion (Sweden), Spectrum Laboratories, Inc. (U.S.), Harvard Bioscience, Inc. (U.S.), Merck KGaA (Germany), and Ala Science (U.S.) among others.

Industry/Innovation/Related News:

Circle Cardiovascular Imaging Inc. (Canada), leading global company developing analytical software for the cardiac imaging community announced the acquisition of Corstem Inc.(Canada), machine learning and artificial intelligence software developer specialized in cardiac imaging analysis to introduce automatic, fully-quantitative myocardial perfusion in cvi42.

The acquisition will further expand Circle’s innovative technology and product offerings with Corstem’s technologies integrated into Circle’s core product – cvi42, including an automatic and comprehensive solution for fully-quantitative myocardial perfusion.

Patient Temperature Monitoring Market Research Report - Forecast to 2023 | MRFR

Positron Emission Tomography Devices Market Research Report - Forecast to 2023 | MRFR

Hair Removal Devices Market Research Report - Forecast to 2023 | MRFR

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Clinical Intelligence Market Key Players, Opportunities and Global Industry Analysis | Forecast to 2023

Clinical Intelligence Market Information: By Type (CDSS, Quality Improvement), Component (Service, Software), Application (Clinical, RCM), End User (Hospitals, Clinics, Tpas) - Global Forecast Till 2023

Clinical intelligence is a new learning paradigm for healthcare providers in which clinical data is analyzed with the use of modern data mining, data visualization, and predictive modeling tools to improve healthcare delivery. The usage of clinical intelligence is becoming a common phenomenon in healthcare institutes worldwide and the global clinical intelligence market is poised to strike a splendid CAGR of 12.5% over the forecast period of 2017-2023, predicts Market Research Future (MRFR) in an exhaustive study.

The pressing need to curb healthcare costs has been the primary drive motivating the growth of the global clinical intelligence market. The growing burden of chronic diseases and increasing patient influx in hospitals has raised the adoption of software solutions for tedious process such as insurance claim processing and fraud detection. This results in improved healthcare outcomes and subsequently boosts the growth of the market.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/4478

Growing interest by the healthcare sector towards making data-driven decisions and growing integration of Big Data analytics is also acting as a plus for the market growth. Moreover, growing demand for precision and personalized medicine has spurred the adoption of clinical intelligence on a global scale.

Other factors stimulating the market growth include governments in multiple countries encouraging the adoption of clinical intelligence solutions. Furthermore, constant changes in regulations, increasing reporting mandates, and ever-increasing competition, healthcare organizations can no longer ignore the importance of clinical intelligence. Clinical intelligence aids healthcare sector to improve the quality of care by analyzing the gaps in their care, patient safety, efficiency, and cost-effectiveness.

On the other hand, a general lack of regulatory and clinical standards for predictive analytics is likely to hinder the growth of the market. The high cost of clinical intelligence software might restrain the growth of the market growth in developing countries.

Segmentation

The global clinical intelligence market has been segmented based on component, type, end-user, and application.

By type, the global clinical intelligence market has been segmented into population health management, retrospective performance measures & predictive analytics, clinical benchmarking, clinical decision support (CDSS) system, quality improvement, performance measurement systems, and others. The quality improvement segment has been further segmented into six sigma. The population health management segment has been further segmented into under-utilization of health services and over-utilization of health services.

By component, the global clinical intelligence market has been segmented into hardware, software, and services.

By application, the global clinical intelligence market has been segmented into revenue cycle management (RCM) claims, fraud, supply chain, financial management, clinical, and others.

By end-users, the global clinical intelligence market has been segmented into clinics, hospitals, TPAs, and others.

Regional Analysis

By region, the global clinical intelligence market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas account for the maximum share of the global clinical intelligence market owing to high usage of software solutions for healthcare administration. The presence of healthcare IT companies in the region and high healthcare expenditure supports market growth in the region. Additionally, growing usage of Decision Support System among tertiary care centers in the US has proven to be beneficial for the growth of the market.

Europe follows the Americas closely and is the second largest market for clinical intelligence. Increase in a number of healthcare institutions who are leveraging clinical intelligence management softwares and expanding healthcare expenditure boosts the market growth in Europe.

APAC is poised to be the fastest growing market for clinical intelligence. Development of healthcare IT infrastructure, increasing healthcare expenditure and the growing presence of key players in the region can be credited for the growth of the market. Besides, the growing burden of diseases and government initiatives towards the modernization of the healthcare system are also factors favoring market growth in APAC.

The MEA market is expected to showcase moderate growth. The Africa region, in particular, will exhibit limited growth due to low healthcare penetration and low healthcare expenditure.

Competitive Landscape

The notable players in the clinical intelligence market include General Electric Company (U.S.), QSI Management, LLC (U.S.), Allscripts (U.S.), Cerner Corporation (U.S.), IBM (U.S.), Epic Systems Corporation (U.S.), Greenway Health, LLC (U.S.), McKesson Corporation (U.S.), and eClinicalWorks (U.S.).

Industry Updates

February 2019- Nuance Communications, US-based multinational computer software technology corporation, introduced its new clinical intelligence solution dubbed Ambient Clinical Intelligence at the 2019 Healthcare Information and Management Systems Society (HIMSS). The new solution is built on speech recognition technology of its Dragon Medical One cloud platform and would facilitate hands-free clinical documentation.

Brows More Healthcare Related Research Reports

ENT Devices Market Overview, Growth Analysis, Industry Size and Forecast to 2023

Substance Abuse Treatment Market Research Report - Forecast to 2023 | MRFR

Lip Augmentation Market Research Report - Forecast to 2023 | MRFR

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Fetal Macrosomia Market Landscape, Overview and Segmentation To 2023

Fetal Macrosomia Market Growth And Trends Analysis By Diagnosis (Ultrasound, Antenatal Testing, And Others), By Treatment (Medical Care, Surgical Care, And Others), By End User- Global Forecast Till 2023

Fetal Macrosomia Market Segmentation:

Global fetal macrosomia market has been segmented on the basis of diagnosis which comprise of ultrasound, antenatal testing, and others. Ultrasound is further sub-segmented into standard ultrasound, transvaginal scan, fetal echocardiography, 3-d ultrasound, dynamic 3-d ultrasound, and others. Antenatal testing is further sub-segmented into blood and urine tests, amniocentesis, chorionic villus sampling, and others.

On the basis of treatments, the market has been segmented into medical care, surgical care, and others. Surgical Care is sub-segmented into cesarean delivery, and others.

On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.

Fetal Macrosomia Market Regional Analysis:

Global scenario of the fetal macrosomia market, there are four main regions, America, Europe, Asia Pacific, and Middle East & Africa.

Eastern European countries are also showing significant growth in this market. Asia Pacific market is witnessing rapid growth due to increasing awareness of the diseases, increasing spending and government initiative to increase awareness as well as to provide affordable healthcare. Talking about the market scenario of Middle East & Africa, this region is expected to grow slower than the global average due to various inhibiting factors such as lack of knowledge, limited access to the required healthcare facilities, traditional healthcare facilities etc.

America is the largest market for fetal macrosomia. The Americas mainly include North America and South America. North America is holding the largest market share in which US is dominating this market. Some major factors like advanced diagnostic and treatment facilities, rapid adoption of healthcare practices, and increasing investment in research are the driving forces for the growth for North America fetal macrosomia market. European region is the second important market, especially West European countries are dominating this region.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/4002

Overview

Fetal Macrosomia Market Highlights

The Fetal Macrosomia Market to reach around USD 2290.2 million in 2016 and is expected to reach USD 3034.1 million by 2023 which is a projected CAGR of 4.1%. Companies are investing in development of new and innovative device development is also key driver for the market growth. Major players in fetal macrosomia market: There are plenty of large and small market players which operate in this market: Carestream Health (US), Esaote SpA (Italy), Fonar Corporation (US), Fujifilm Holdings Corporation (Japan), GE Healthcare (UK), Hitachi Medical Corporation (Japan), Hologic, Inc. (US), Philips Healthcare (Netherlands), Samsung Medison Co. Ltd (Republic of Korea), Shimadzu Corporation (Japan), Siemens Healthcare (Germany), Toshiba Corporation (Japan),) and others.

The global fetal macrosomia market has been evaluated as a steady market and it is expected to continue growing soon. Increasing incidence of fetal macrosomia is the major driver for this market. Introduction and increasing adoption of advanced diagnostic tools for effective diagnostic and treatment management is another important factor for the market growth.

Brows More Healthcare Related Research Reports

Care Management Solutions Market Research Report –Global Forecast to 2023| MRFR

Leukapheresis Products Market Research Report - Forecast to 2023 | MRFR

Facial Injectors Market Research Report - Forecast to 2023 | MRFR

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Nanobots Market Insights, Solutions and Services Till 2025

Global Nanobots/Nanorobots Market: Information by Product Type (Nanomanipulator, Bio-Nanorobotics, Magnetically Guided Nanobots/Nanorobots), Application (NanoMedicine, Biomedical), Region (Americas, Europe, Asia-Pacific and the Rest of the World) - Forecast till 2025

The pathbreaking developments in robotics are expected to create favorable demand for nanorobots. Reports that evaluate the medical device industry have been made accessible by Market Research Future, which creates reports on several industry verticals that review the market development and prospects. The nanobots market is projected to be motivated to attain USD 100 billion in earnings while flourishing at a CAGR of 21 % in the forecast period.

The use of nanorobots is drastically modifying the landscape for treatment delivery in the healthcare sector. The need to achieve reliable treatment results is anticipated to motivate the market for nanobots in the coming years. Increased understanding of the operation of nanobots is expected to lead to increased implementation, thus motivating the market for nanobots.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/1301

Segmental Analysis

The segmental assessment of the nanobots market has been carried out on the basis of type, application, and region. On the basis of type, the nanorobots market is segmented into respirocyte nanorobots, microbivore nanorobots, clottocyte nanorobots, and cellular repair nanorobots. The other types of nanobots are bacteria-powered robots and nanoswimmers. Based on the application, the nanobots market is segmented into biomedical, nano medicine, mechanical, and other applications. Based on the region, the nanobot market is segmented into North America, Asia Pacific, Europe, the Middle East, and Africa.

Detailed Regional Analysis

The regional analysis of the nanobots market comprises of regions such as Asia Pacific, North America, Europe, the Middle East, and Africa. The North American region is the principal market for nanobots. The North American regional market for nanobots is projected to develop at a CAGR of 12.2% and is projected to attain USD 73 billion from USD 55 billion in 2016 by the conclusion of the forecast period. The awareness related to the use of nanobots for surgical care and treatment of patient’s factor is driving the market in the North American region. The European region is the second chief market for nanobots. Whereas, the Asia Pacific region is projected to be the fastest increasing market for nanobots. India is likely to flourish progressively in this market as the application of this technology entails a large amount of financial investment by the healthcare organizations and also enhanced training for the staff. Most of the hospitals are primarily focusing on providing primary healthcare to patients. The market also shows solid growth in the Middle East and African region.

Competitive Analysis

The decrease in trade restrictions is anticipated to create favorable opportunities for development in the forecast period. The presence of favorable trade policies is anticipated to improve the growth of the market in the impending period. Strong insights into the market’s condition are motivating the expansion of the forecast period. The offering in the market has also diversified considerably ensuring availability of better-quality products in the market. Amplified investment in the market is likely to motivate the positive changes in the market in the forecast period. The emergence of specialization in production has also increasingly improved the growth trajectory of the market. The efficiencies achieved in the allocation of resources is expected to encourage the development of the market in the approaching period. Moreover, increased cost efficiencies are projected to positively impact the progress of the market in the coming years.

The notable players functioning in the nanobots market are Zymergen Inc. (U.S), Ginkgo Bioworks (U.S), Synthace Limited (U.K), Advanced Diamond Technologies (U.S), Xidex Corp. (Texas), and Advanced Nano Products Co Limited (South Korea) to name a few.

Industry Updates:

A team has planned on using nanobots to generate the ‘internet of thoughts,’ where prompt knowledge could be transferred just by thinking it. A global team of scientists led by associates of the US Institute for Molecular Manufacturing and UC Berkeley predicts that exponential development in nanomedicine, nanotechnology, artificial intelligence (AI) and computation will direct this century to the expansion of a human ‘brain-cloud interface’ (B-CI).

A team of scientists at ETH Zurich and EPFL have designed a bacteria-inspired nanorobot design that is biocompatible, able to modify its shape as needed and can circulate through narrow blood vessels without conceding on speed.

Brows More Healthcare Related Research Reports

Hematology Diagnostics Market Research Report –Global Forecast to 2023| MRFR

Aseptic Sampling Market Research Report –Global Forecast to 2023| MRFR

Odontogenic Tumor Market Research Report –Global Forecast to 2023| MRFR

Healthcare Information Governance Solution (IGS) Market Opportunities, Sales, Cost and Profit By 2027

Healthcare Information Governance Solution Market Research Report, by Type (eDiscovery,), Deployment (Web and Cloud, In-Premise), by Applications (Financials, Records), by End-User (Hospitals and Clinics, Research and Academics) - Global Forecast Till 2027

Market Insight

The latest setups in Healthcare Information Governance Solution (IGS), which comprises of management of healthcare information, is effectively promoting the development of the market. Market reports associated to the healthcare industry have been made available by Market Research Future, which states that the global healthcare Information Governance Solution (IGS) market is anticipated to prosper at a CAGR of 16.7 % during the forecast period from 2017 to 2023.

Healthcare information governance is a high-pressure part of the healthcare industry where a lapse in providing accurate information regarding health issues can result in significant blunder. Thus, the application of healthcare information governance solutions balances and reduces the risk by enabling proper management of healthcare information to a great extent. The management of healthcare information includes the implementation of processes, controlling, metrics, and retrievals of information that is provided in a suitable format whenever demanded. Healthcare information governance systems are also important in improving operations of healthcare information and aims in making a business asset available in a cost-effective way only to ensure compliance and reduce the cost of non-compliance.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/757

Market Drivers & Trends

The global Healthcare Information Governance Solution market is mainly driven by factors such as the rising cost of legal risks as well as increasing stringency of regulations. As per the research and study, compliance reduces the legal risks associated with weak and inconsistent information. Another factor that is remarkably driving the market to achieve its valuation is the centralization of the data, which is fragmented across various domains that increases its accessibility and flow speed.

On the other hand, the beneficiaries of Healthcare Information Governance Solution to the health organizations in the events o lawsuit, compliance audit or corporate merger is also capturing the market share, which is anticipated to grab higher CAGR and revenue over the assessment period. Furthermore, development of the field of biotechnology and pharmaceutical sectors, increasing costs of noncompliance, rising expectations from data management and information technology systems have eventually bolstered the market in recent years. Based on these factors, the U.S. is recorded to be the largest market share for biopharmaceuticals by gaining one-third of the global market. It is expected that the U.S. biopharmaceutical sector to account approximately 17% of all the domestic research & development funded by the U.S. businesses and added an estimated USD 1.2 trillion in the economic output of 2014.

However, on the flip side, the global Healthcare Information Governance Solution market has some restriction over its growth graph due to factors such as high costs of the information governance system, varied cultures of secrecy, traditional structures of organization and fragmented data structures and more.

Detailed Regional Analysis

The regions included in the regional analysis of the global Healthcare Information Governance Solution market are North America, the Middle East, Europe, Asia Pacific, and Africa.

The foremost regional analysis of the market observes that the Americas region is the major region in the global market owing to favorable insurance penetration, excellent reimbursement scenario, and increasing expenditure on healthcare. The high consumption of information technology has boosted the market and have been developing new technology in the U.S., which has augmented the market competition.

The European region is the next primary market owing to the availability of funds for research and growing pharmaceutical and biotechnology sectors. The study depicted that in 2017, according to the Biotechnology and Biological Sciences Research Council, the U.K. pharmaceutical market is anticipated to progress at an average annual growth rate of 4 to 7% by 2021.

On the other side, Asia Pacific is also projected to be the fastest-growing region for the market with the support of the presence of continuously developing economies such as India and China and a developing healthcare sector mainly in these countries. Whereas, the Middle East and Africa have the least share of the healthcare Information Governance Solution (IGS) market, which can be attributed to the incidence of weak economies, rigorous government policies, and lack of healthcare services, especially within the African region. The Middle East grabs most of the market share in the Middle East and Africa.

Key Players

The significant players in the healthcare Information Governance Solution (IGS) Market are listed as electronic Medicines Compendium (U.S.), HP Autonomy (England), Symantec Corporation (U.S.), Information Governance Solutions, LLC. (U.S.), FTI Consulting, Inc. (U.S.), Google (U.S.), Microsoft (U.S.), Hewlett Packard Enterprise Development LP (U.S.), Veritas Technologies (U.S.), NovaDigm Therapeutics (U.S.), iDiscovery Solutions, Inc. (U.S.), and others

Brows More Healthcare Related Research Reports

Global Artificial Eye Market Research Report- Forecast To 2023 | MRFR

Transradial Access Devices Market Research Report –Global Forecast to 2023| MRFR

Drug Infusion System Market Research Report –Global Forecast to 2023| MRFR

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Tuesday 28 July 2020

Impact of COVID-19 on Healthcare Market Size, Share, Emerging Trends By 2022

COVID-19 Impact on Healthcare Market Segmentation

The Global COVID-19 Impact on Healthcare Market Report has been covered for various sectors including medical devices/equipment, diagnostics, pharmaceuticals, technology, Healthcare IT, health insurance, medical tourism, and healthcare facilities.

The medical devices/equipment has been divided into medical ventilators, imaging devices, hospital beds, masks, personal protective equipment, sanitation, and nurse call systems. Medical ventilator Market size is expected to Witness significant growth owing to widespread use of ventilators during this COVID-19 outbreak has substantially raised the production bar of prominent players across the globe. Currently, there are about 170,000 ventilators in the US and another 12,700 in the National Strategic Supply, a cache of medical supplies maintained by the federal government to respond to national emergencies. Moreover, the prominent players are also keen on increasing their production capacities. This move has been worked out by many players, including Vyaire Medical, Hamilton Medical, and Medtronic, to sufficiently aid the medical facilities and hospital settings. The market for ventilators is expected to grow at a rate of more than 35% in the coming months as more players are manufacturing these products. In addition, the market in 2019 might not see the dominance of specific players. Furthermore, ease of regulation might increase the number of new entrants in the market.

The COVID-19 infection has increased the usage of masks exponentially. To meet the increasing demand for masks, many companies such as Reliance Industries Ltd. (India) have started the production of face masks in India. In early March 2020, the World Health Organization (WHO) has called to increase the production of masks by 40% to meet about 89 million mask demand per month from medical workers working in the frontline. Before the outbreak, China has manufactured more than half of the world’s masks. The corona outbreak has resulted in an increase in the production of masks to 100 million units in China and the production of N-95 masks has reached 1.6 million units. The manufacture of masks has increased by 12-fold in the country.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/9547

The diagnostics sector is further categorized into analyzers, kits & reagents, and consumables. The demand for diagnostics test kits has spiked since the past few months. Several companies have increased their production to meet the global demand. The companies are also launching new cost-effective rapid tests with low turn-around time. In April, Bione, an Indian company, launched a new screening test kit for at-home use.

The product is approved by the Indian Council of Medical Research (ICMR) and displays the results in 5 to 10 minutes. The cost of these test kits is between USD 25 to USD 30. The company claims to supply 20,000 kits per week. Furthermore, in February, PCL, a South Korean IVD company has launched a testing kit, named COVID-19 Ag GICA Rapid, to detect COVID-19 with a turn-around time of 10 minutes. The test kit uses nasal discharge as a sample with an accuracy rate of around 85 percent.

The pharmaceutical is further segmented into vaccines and drugs. Several pharma companies are striving hard to advance potential therapeutics or vaccines towards the current situation. Currently, there are two candidate vaccines under Phase 1 clinical trial being developed by CanSino Biological Inc. with the Beijing Institute of Biotechnology and Moderna/NIAID. Also, there are around 42 candidate vaccines in the pre-clinical stage being developed by companies such as Inovio Pharmaceuticals, Takis/Applied DNA Sciences/Evvivax, Zydus Cadila, Sinovac, Codagenix/Serum Institute of India, and Sanofi Pasteur among others.

The approval of any new pharmaceutical products to fight the coronavirus pandemic would be credit positive for the pharma companies involved. But the revenue opportunities for these products are difficult to estimate due to the uncertainty surrounding the severity and the duration of the pandemic, as well as other variables. These include the probability of success, the ability to scale up manufacturing, the level of competition, and product pricing, which would likely vary by region.

The Healthcare IT sector is categorized into telehealth, mHealth, ePharmacy, and EHR/EMR. Telehealth is playing a crucial role in relieving the burden of COVID-19 on hospitals. For instance, the FCC has developed and approved a USD 200 million programs to fund telehealth services and devices for medical providers. The support provided through the COVID-19 Telehealth Program will help eligible health care providers purchase telecommunications services, information services, and devices necessary to provide critical connected care services, whether for treatment of coronavirus or other health conditions during the coronavirus pandemic.

In addition to this, several startup companies are taking this opportunity to launch a new product in telehealth. For instance, Pager, a New York-based digital health startup has announced that it has developed an additional AI (artificial intelligence) feature specific to COVID-19 triage and risk assessment to its care navigation and telemedicine platform. This product is offered white-labeled to health system providers and health insurance payers. Telehealth not only caters to the need of target patients but also helps to mitigate the imbalances and shortages of healthcare professionals. Thus, new product launches, favorable government initiatives, and awareness among the population are expected to boost the application of telehealth during the COVID-19 crises.

COVID-19 Impact on Healthcare Market Regional Outlook

The COVID-19 Impact on Healthcare Market has been divided, by region, into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. The US is expected to account for the largest number of COVID-19 cases followed by Spain, Italy, Germany, France, and China. The study includes the impact of COVID-19 in North America with the US, Canada, and Mexico, whereas South America is categorized into Brazil and the Rest of South America. The countries included in the European regional study include Germany, France, the UK, Italy, Spain, the Netherlands, Belgium, Switzerland, and the rest of Europe. The impact analysis also covers Asia-Pacific segmented into Japan, China, India, South Korea, Australia & New Zealand, and the rest of Asia-Pacific. The study in the Middle East & Africa has been divided into Saudi Arabia, Iran, Africa, and the Rest of MEA.

COVID-19 Impact on Healthcare Market Highlights

The COVID-19 outbreak has severely impacted the entire supply chain in the healthcare industry from the procurement of raw materials to production and distribution. The need for medical ventilators at a global level has triggered the manufacturers to increase production by up to 40% to 50%. The manufacturers have also collaborated with automakers to meet the growing demand. For instance, as of 30 March 2020, GE Healthcare and Ford Motors entered into a strategic partnership. As per the agreement, Ford Motors will provide its manufacturing capabilities to quickly scale production, and GE Healthcare will provide its clinical expertise and will license the current ventilator design from Airon Corporation, a US-based privately held company specializing in high-tech pneumatic life support products.

According to MRFR analysis, the COVID-19 pandemic is expected to pose a huge impact on the overall healthcare industry. Governments and various associations in conjunction with several market players are actively participating in facing the current crisis. The key players are involved in research and development activities, strategic collaborations & partnerships, and new product launches, to cater to the current needs of vaccines, drugs, diagnostics, and medical devices such as ventilators.

Browse More details at: https://www.marketresearchfuture.com/covid-19-analysis/covid-19-impact-healthcare-market-9547

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Micro pump Market Dynamics, Analysis and Insights By 2023

Global Micropump Market : Information by Product Type (Mechanical Micropump, Piezoelectric Micropump, Syringe Pump, Peristaltic Pump and Non-Mechanical Micropump), Material (Polymer, Glass and Silicon), Application (Drug Delivery Systems, Medical Device and In-Vitro Diagnostics), End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers and Research Institutes) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

Global Micro-Pump Market Players:

The major participants of this micro-pump market are Advanced Microfluidics SA, Alldoo Micropump, Bio-Chem Fluidics, Cole-Parmer Instrument Company LLC., Dolomite Centre Ltd, IDEX Corporation, KNF Neuberger Inc., Microfluidica LLC, Servoflo Corporation, Takasago Electric Inc., TOPS Industry & Technology Co. Ltd., World Precision Instruments, Xavitech and others.

Segmentation:

Micro-pump market has been segmented on the basis of types which comprises of mechanical and non-mechanical. On the basis of industry, market is segmented into pharmaceutical, medical devices, in-vitro diagnostics and others.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/1300

Overview

The global micro-pump market has been evaluated as rapidly growing market and expected that the market will reach high growth figures. Micro-pumps have been playing a crucial role in the pharmaceutical industry for last few years. Especially in the processes such as drug discovery, development and delivery. The ability of micro-pump to provide a controlled flow of fluids and controlled delivery of drug dosage into the body of the patients are the major factors boosting the demand for such techniques.

This has led to the improved healthcare management and better medical outcomes. Growing demand for micro-pump technology in the medical and pharmaceutical industry has played an important role in the growth of the micro-pump market. Point of care testing is increasing widely due to lifestyle changes, aging population, and growing chronic diseases.

Point of care testing (POCT) involves the performance of a test close to the site of patient care to provide immediate results outside the conventional laboratory environment. The role of micro-pumps has been instrumental in the point of care services. Additionally, different types of materials are used to manufacture different micro-pump in order to ensure their compatibility with the extensive range of fluids. Due to these innovations in the material mix of microfluidic pumps, the opportunities for new entrants is increasing in the market, thus driving the growth of the overall market.

Proper drug delivery is the most important part of the drug administration. There has been rising awareness about the importance of the controlled drug delivery. Efforts are being taken to provide treatments for diseases like osteoporosis, infertility, Parkinson, Alzheimer, multiple sclerosis, among others through micro-pumps which will enhance the growth of the micro-pump market.

On the other hand, there are certain factors that can hinder the growth of the micro-pump market. The regulatory issues act as hindrance in the development of micro-pump market. Apart from regulatory challenges, the market also confronts issues from surface chemistry and geometrical problem during manufacturing process.

Regional Analysis:

Depending on geographic region, micro-pump market is segmented into four key regions: North America, Europe, Asia Pacific, and Rest of World. Globally North America is the largest market for micro-pump. The North America market for micro-pump is expected to grow at CAGR 17.6% during the forecasted period. Europe is the second-largest market for micro-pump which is expected to grow at a CAGR of 17.4%. Asia-Pacific region is expected to be fastest growing region in micro-pump market.

Access Report Details @ https://www.marketresearchfuture.com/reports/micro-pump-market-1300

Browse More Reports at:

Meralgia Paresthetica Market Research Report - Forecast to 2023 | MRFR

Nystagmus Market Size, Application | Dynamics, 2023

Pediatric Neurology Devices Market Research Report- Forecast to 2023 | MRFR

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand,

Market Research Future

Office No. 524/528, Amanora Chambers

Magarpatta Road, Hadapsar

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com